Searched for: subject:"Cystic%5C+fibrosis"
(1 - 14 of 14)
document
Bouva, M. (author), Heijnen, M.L. (author), Jacobs, B. (author), van der Ploeg, C.P.B. (author), Gille, J. (author), Gulmans, V. (author), Verschoof-Puite, R. (author), de Winter-de Groot, K. (author)
public lecture 2021
document
van der Does, A.M. (author), Amatngalim, G.D. (author), Keijser, B.J.F. (author), Hiemstra, P.S. (author), Villenave, R. (author)
The respiratory tract harbours a variety of microorganisms, collectively called the respiratory microbiota. Over the past few years, alterations in respiratory and gut microbiota composition have been associated with chronic inflammatory diseases of the lungs. How these changes influence disease development and progression is an active field of...
article 2018
document
van der Ploeg, C.P.B. (author), van den Akker-van Marle, M.E. (author), Vernooij-van Langen, A.M.M. (author), Elvers, L.H. (author), Gille, J.J.P. (author), Verkerk, P.H. (author), Dankert-Roelse, J.E. (author), Loeber, J.G. (author), Triepels, R.H. (author), van der Pal, S.M. (author), Dompeling, E. (author), Pals, G. (author), Gulmans, V.A.M. (author), Oey-Spauwen, M.J.W. (author), Wijnands, Y.H.H.M. (author), Castricum, L.M. (author), Arets, H.G.M. (author), van der Ent, C.K. (author), Tiddens, H.A.W.M. (author), de Rijke, Y.B. (author), Yntema, J.B. (author)
BACKGROUND: Previous cost-effectiveness studies using data from the literature showed that newborn screening for cystic fibrosis (NBSCF) is a good economic option with positive health effects and longer survival. METHODS: We used primary data to compare cost-effectiveness of four screening strategies for NBSCF, i.e. immunoreactive trypsinogen...
article 2015
document
Vernooij-van Langen, A.M.M. (author), van der Pal, S.M. (author), Reijntjens, A.J.T. (author), Loeber, J.G. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
Background: False-positive screening results in newborn screening for cystic fibrosis may lead to parental stress, family relationship problems and a changed perception of the child's health. Aim of the study: To evaluate whether parental anxiety induced by a false positive screening result disappears after six months and to assess whether a...
article 2014
document
Vernooij-van Langen, A.M.M. (author), Reijntjes, S. (author), van der Pal, S.M. (author), Loeber, G.J. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
article 2013
document
Vernooij-van Langen, A.M.M. (author), Reijntjens, S. (author), van der Pal, S.M. (author), Loeber, J.G. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
Purpose: Most newborn screening (NBS) strategies for Cystic Fibrosis (CF) also identify carriers. However, it is unclear if parents want to be informed about their child's carrier status or not. Methods: Focus group discussions with pregnant couples to explore their opinions about disclosure of a carrier result for CF of their newborn. Results:...
article 2013
document
Vernooij-van Langen, A.M.M. (author), Reijntjens, S. (author), van der Pal, S.M. (author), Loeber, J.G. (author), Dompeling, E. (author), Dankert-Roelse, J.E. (author)
article 2011
document
van Dommelen, P. (author), Grote, F.K. (author), Oostdijk, W. (author), Keizer, Muinck de (author), Schrama, S.M.P.F. (author), Bouquet, J. (author), Hendriks, J.J.E. (author), Kouwenberg, J. (author), Verkerk, P.H. (author), van Buuren, S. (author), Wit, J.M. (author), TNO Kwaliteit van Leven (author)
Background/Aims: Cystic fibrosis (CF) in infancy and childhood is often associated with failure to thrive (FTT). This would suggest that in countries without a newborn screening program for CF, FTT could be used as a clinical screening tool. The aim of this study is to assess the diagnostic performance of FTT for identifying children with CF....
article 2009
document
Grote, F.K. (author), van Dommelen, P. (author), Oostdijk, W. (author), de Muinck Keizer-Schrama, S.M.P.F. (author), Verkerk, P.H. (author), Wit, J.M. (author), van Buuren, S. (author), TNO Kwaliteit van Leven (author)
Objective: To establish evidence based guidelines for growth monitoring on a population basis. Study design: Several auxological referral criteria were formulated and applied to longitudinal growth data from four different patient groups, as well as three samples from the general population. Results: Almost 30% of pathology can be detected by...
article 2008
document
Detmar, S. (author), Dijkstra, N. (author), Nijsingh, N. (author), Rijnders, M. (author), Verweij, M. (author), Hosli, E. (author), TNO Kwaliteit van Leven (author), KvL (author)
Background: Advances in genomics will open up opportunities in the fields of genetic testing, early diagnosis and disease treatment. While neonatal screening is the field of application par excellencefor these developments, the debate on its potential benefits and drawbacks is mainly theoretically driven and based on the opinions of...
article 2008
document
Oudshoorn, J.H. (author), Lecluse, A.L.Y. (author), van den Berg, R. (author), Vaes, W.H.J. (author), van der Laag, J. (author), Houwen, R.H.J. (author), TNO Kwaliteit van Leven (author)
OBJECTIVES: Coenzyme Q10 (CoQ10) is an effective lipophilic antioxidant and protects against lipid peroxidation by scavenging radicals. Patients with cystic fibrosis generally have fat malabsorption; thus, we hypothesized that overall plasma CoQ10 concentration in pediatric patients with cystic fibrosis might be diminished. Because these...
article 2006
document
van den Akker-van Marle, M.E. (author), Dankert, H.M. (author), Verkerk, P.H. (author), Dankert-Roelse, J.E. (author), TNO Kwaliteit van Leven (author)
OBJECTIVES. The purpose of this work was to assess the costs of 4 neonatal screening strategies for cystic fibrosis in relation to health effects. In each strategy, the first test was the measurement of serum concentration of immunoreactive trypsin. The second step consisted of either a second immunoreactive trypsin test (strategy 1) or a...
article 2006
document
van Wouwe, J.P. (author), Verkerk, P.H. (author), Mattiazzo, G.F. (author), El Mokadem, N. (author), Hirasing, R.A. (author)
article 2002
document
Schaapveld, K. (author), Hirasing, R.A. (author), Jol-Japin, W.F. (author), TNO Preventie en Gezondheid (author)
article 1992
Searched for: subject:"Cystic%5C+fibrosis"
(1 - 14 of 14)